Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nerve block showdown: which technique cuts hernia surgery pain best?

NCT ID NCT07676123

Symptom relief Sponsor: Ankara University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial compares two types of nerve blocks—Quadratus Lumborum and Ilioinguinal-Iliohypogastric—given before laparoscopic inguinal hernia repair. The goal is to see which block reduces the need for opioid painkillers during surgery and lowers the risk of long-term pain afterward. Adults having their first hernia repair and without chronic pain are eligible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If one block proves better, it could become the standard for reducing pain and opioid use after hernia surgery.
What could go wrong
This is a small, early-stage comparison. Results may not apply to all patients, and individual responses to nerve blocks vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 66 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have not undergone previous inguinal hernia surgery * Age 18 and over * ASA physical status I-III * BMI: 18-30 kg/m² * Literate * No known cognitive impairment * Patients who are willing to participate in the study and provide informed consent * No history of chronic pain and no chronic analgesic or opioid use Exclusion Criteria: * Age under 18 * ASA physical status IV or higher * BMI \> 30 kg/m² * Presence of any chronic pain * Chronic opioid consumption * Known cognitive impairment * Illiterate * Visual or hearing impairment * Infection at the injection site * Coagulopathy * Chronic hepatic or renal failure * Peripheral neuropathy * Allergy to local anesthetics * Cardiac rhythm disorders, central/autonomic nervous system diseases, or presence of a pacemaker * Use of medications that affect cardiac autonomic regulation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mesh C23.300.707.374.875 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Acute Pain Chronic Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mesh C23.300.707.374.875 Mesh C23.550.767.700 Mesh C23.550.767.859 Mesh E01.370.388.250.520 Mesh E03.155.086.711

Contacts and locations

Locations

  • Ankara University

    Ankara, Turkey (Türkiye)